CytoAgents, Inc logo

CytoAgents, Inc

Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for multiple areas of high unmet need.

10 employees · est. 2018 · Pittsburgh, United States

VS
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

Changing the future of Oncology

208 employees · est. 2003 · South San Francisco, United...

Sutro Biopharma, Inc. is the older company (2018 vs 2003); Sutro Biopharma, Inc. is the larger of the two.

Side-by-Side Comparison

CytoAgents, Inc Sutro Biopharma, Inc.
Founded
2018 2003 older
Headquarters
Pittsburgh, United States South San Francisco, United States
Employees
10 208 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Information Technology
Funding Stage
Series A IPO
Total Funding
$22.60M $745.90M
Funding Rounds
9 12
Services
Development of CTO1681, Clinical Trials in Oncology and Inflammatory Diseases, Immunomodulatory Treatments Development of single- and dual-payload ADCs, Oncology research and therapeutics, Scientific and clinical advisory services
Target Customers
Patients with Inflammatory Diseases, Cancer Patients Undergoing CAR T-Cell Therapy, Healthcare Organizations and Providers Cancer patients, Healthcare providers, Biopharmaceutical investors, Scientific community
Taxonomy
Clinical Stage, Pharmaceutical Products, Immune System, Inflammation, Cytokine Release Syndrome, Drug Development, Novel Approach, Multi-organ Disease, Innovative Treatment, Unmet Medical Needs Oncology Therapeutics, Cancer Treatment, Antibody Drug Conjugates, Exatecan, Protein Engineering, Biopharmaceutical Development, XpressCF Technology, Cell-free Protein Synthesis, Clinical Stage Drug Development, Multiple Myeloma, Non-Hodgkin Lymphoma, Ovarian Cancer, Endometrial Cancer, Biotechnology Partnerships, Therapeutic Innovation
Website
cytoagents.com sutrobio.com
CytoAgents, Inc logo

About CytoAgents, Inc

CytoAgents, Inc, a promising Biotechnology and Health Care company based in the United States, was founded in 2018 with the mission of tackling Cytokine Release Syndrome (CRS). This clinical stage company is innovating the treatment of severe immune responses using its lead drug candidate, GP1681. B...

Sutro Biopharma, Inc. logo

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a pioneering player in the oncology sector, driven by its commitment to transform cancer treatment. The company, with the slogan "Changing the future of Oncology," leverages its proprietary XpressCF® technology to develop precisely designed cancer therapeutics, aiming to gre...

We will tell you when either one moves

BounceWatch watches CytoAgents, Inc and Sutro Biopharma, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CytoAgents, Inc and Sutro Biopharma, Inc. — by email.

Frequently Asked Questions

CytoAgents, Inc — Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for multiple areas of high unmet need.. Sutro Biopharma, Inc. — Changing the future of Oncology. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CytoAgents, Inc has raised $22.60M while Sutro Biopharma, Inc. has raised $745.90M.
CytoAgents, Inc and Sutro Biopharma, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CytoAgents, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CytoAgents, Inc on 12 Sep 2024, and Sutro Biopharma, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes